Return to Clinical Trials Search Results

Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study

Evaluate the effectiveness of Boston Scientific (BSC)'s LV MSP (Left Ventricular MultiSite Pacing) feature in the Resonate family of CRT-D devices and confirm safety in a post approval study when used in accordance with its approval labeling.